Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates by Zwaagstra, John C, Sulea, Traian, Baardsnes, Jason, Radinovic, Stevo, Cepero-Donates, Yuneivy, Robert, Alma, O'Connor-McCourt, Maureen D, Tikhomirov, Ilia A, Jaramillo, Maria Luz

Get full text

Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile by Garrido, Greta, Tikhomirov, Ilia A., Rabasa, Ailem, Yang, Eric, Gracia, Elías, Iznaga, Normando, Fernández, Luis E., Crombet, Tania, Kerbel, Robert S., Pérez, Rolando

Get full text

Abstract 1778: Nimotuzumab, a humanized antiepidermal growth factor receptor antibody, interacts with EGFRvIII by Jaramillo, Maria L., Grothe, Suzanne, Baardsnes, Jason, Banville, Myriam, Paul-Roc, Beatrice, Tikhomirov, Ilia A., Thompson, Sean EL, O'Connor, Maureen

Get full text

Activin and GDF Ligand Trap HS235: First-in-class Lean Body Mass-Preserving Anti-Obesity Agent by Schang, Gauthier, de Molliens, Mathilde Poujol, Brule, Emilie, Chauvet, Cristina, Sours, Ariane, Denis, Jean-Francois, Tikhomirov, Ilia, Ganesh, Vannakambadi, Tremblay, Gilles, Schoelermann, Julia, Connor-McCourt, Maureen O

Get full text

HS135, A NOVEL ACTIVIN AND GDF TRAP, IS EFFICACIOUS IN EXPERIMENTAL PULMONARY HYPERTENSION AND HEART FAILURE by Schang, Gauthier, Molliens, Mathilde Poujol De, Brule, Emilie, Chauvet, Cristina, Denis, Jean-François, Ganesh, Vannakambadi, Schoelermann, Julia, Tremblay, Gilles, Tikhomirov, Ilia

Get full text

HS135, A Best-in-class Activin And GDF Ligand Trap, Is Efficacious In Experimental Left Heart Failure by Schang, Gauthier, de Molliens, Mathilde Poujol, Brûlé, Emilie, Sours, Ariane, Chauvet, Cristina, Denis, Jean-François, Ganesh, Vannakambadi, Tikhomirov, Ilia, Tremblay, Gilles, Schoelermann, Julia, O'Connor-McCourt, Maureen

Get full text

In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and t... by Fasih, Aisha, Fonge, Humphrey, Cai, Zhongli, Leyton, Jeffrey V, Tikhomirov, Ilia, Done, Susan J, Reilly, Raymond M

Get full text

Abstract 4551: 111In-NLS-Nimotuzumab: A potent auger electron-emitting radiotherapeutic agent for EGFR-overexpressing breast cancer by Fasih, Aisha, Reilly, Ray, Tikhomirov, Ilia

Get full text

111In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive an... by Fasih, Aisha, Fonge, Humphrey, Cai, Zhongli, Leyton, Jeffrey V., Tikhomirov, Ilia, Done, Susan J., Reilly, Raymond M.

Get full text

sup 111^In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positi... by Fasih, Aisha, Fonge, Humphrey, Cai, Zhongli, Leyton, Jeffrey V, Tikhomirov, Ilia, Done, Susan J, Reilly, Raymond M

Get full text

111In-Bn-DTP A-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive a... by FASIH, Aisha, FONGE, Humphrey, ZHONGLI CAI, LEYTON, Jeffrey V, TIKHOMIROV, Ilia, DONE, Susan J, REILLY, Raymond M

Get full text

Abstract C49: Combination treatment with metronomic cyclophosphamide and the EGFR monoclonal antibody nimotuzumab is efficacious and non-toxic in a preclinical model of advanced tr... by Mutsaers, Anthony J., Man, Shan, Xu, Ping, Tikhomirov, Ilia, Kerbel, Robert S.

Get full text